This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
PubMed · Acorus calamus var. angustatus Besser: Insight into current research on ethnopharmacological use, phytochemistry, pharmacology, toxicology, and pharmacokinetics. (2023)
PubMed · Acorus calamus: a bio-reserve of medicinal values. (2018)
Reviewed by: HerbAlly Editorial Team, Medical herbalists and healthcare professionals
Calamus root contains active compounds including alpha-asarone and beta-asarone, which are believed to modulate neurotransmitter systems in the brain. These compounds may influence acetylcholine activity and exhibit neuroprotective properties through antioxidant mechanisms. In Ayurvedic tradition, calamus (known as "vacha") is classified as a medhya herb, supporting cognitive function, speech, and learning capacity. Evidence level is C, based primarily on animal studies and traditional use rather than controlled human clinical trials. The precise mechanism remains incompletely understood.
Does calamus root interact with medications?
Calamus root may interact with medications metabolized by the liver, particularly those processed through cytochrome P450 enzymes. Due to potential hepatotoxic effects, calamus should be avoided by individuals taking medications that stress liver function. The herb may potentiate central nervous system depressants and sedatives. Those on anticoagulants, anticonvulsants, or neurological medications should consult a healthcare provider before use. Evidence for specific drug interactions is limited (Level C-D), so conservative caution is warranted.
What is the safe dosage for calamus root?
Traditional adult dosages range from 1-3 grams daily of the dried rhizome, specifically using the diploid variety which contains lower beta-asarone levels. The tetraploid variety should be avoided entirely due to significantly higher concentrations of carcinogenic beta-asarone. Calamus is typically prepared as a decoction, powder, or tincture. Due to safety concerns regarding beta-asarone content, long-term daily use is not recommended. Always source calamus from reputable suppliers who verify the chemotype and asarone content.
Is calamus root safe during pregnancy and breastfeeding?
Calamus root is considered unsafe during pregnancy and breastfeeding. The beta-asarone content in certain chemotypes has demonstrated carcinogenic and mutagenic properties in animal studies, posing potential risks to fetal development. Additionally, calamus may stimulate uterine contractions. Due to these documented safety concerns and insufficient human safety data, pregnant and breastfeeding women should avoid calamus root in all forms. This contraindication applies regardless of variety or preparation method.
What are the traditional uses of calamus root?
Calamus root has been used for centuries in Ayurvedic medicine and Native American traditions. In Ayurveda, it is known as "vacha" and valued as a medhya herb for enhancing cognitive function, speech, and learning. Native American traditions used calamus as a stimulant by chewing the rhizome. Traditionally, it has been employed for digestive complaints, respiratory conditions, and as a general tonic. Evidence supporting these uses is Level C (preclinical studies) and traditional use, with no robust human clinical trial data currently available.
What are the side effects and safety concerns of calamus root?
The primary safety concern is beta-asarone content, which has demonstrated carcinogenic effects in animal toxicology studies. High-asarone varieties, particularly the tetraploid chemotype, pose the greatest risk. Potential side effects include gastrointestinal upset, nausea, and vomiting at higher doses. Long-term use may adversely affect liver health, making it contraindicated for individuals with liver disease. Calamus is banned as a food additive in the United States and several other countries due to carcinogenicity concerns. Evidence level for safety concerns is C.
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Acorus calamus, commonly known as sweet flag, is a perennial herb used in traditional medicine for its diverse pharmacological properties, including neuroprotective and antimicrobial effects [PMID:29389665, PMID:24824923].
Background
Acorus calamus L. is a tall, perennial, grass-like monocot plant from the Acoraceae family [PMID:24824923]. It is a sterile triploid of hybrid origin and is highly valued for its medicinal properties, ornamental appeal, and water purification ability [PMID:39065505, PMID:39683145].
Traditional uses
Traditionally used in Ayurveda, Unani, Siddha, and Chinese medicine for a wide range of ailments including nervous disorders, epilepsy, mental ailments, chronic diarrhoea, dysentery, fever, abdominal tumours, kidney and liver troubles, rheumatism, bronchitis, asthma, and skin diseases [PMID:24824923, PMID:24200497, PMID:29389665]. It is specifically regarded as a 'medhya' drug used to improve intellect and memory power [PMID:24824923].
Active compounds
The plant contains phenylpropanoids, sesquiterpenoids, and monoterpenes, with alpha-asarone and beta-asarone being the predominant bioactive components [PMID:32325895, PMID:24200497]. Other identified compounds include tatanan A [PMID:29655694], neo-acorane A, acoric acid, and calamusin D [PMID:28346359], as well as specific lignans and furan derivatives [PMID:37343685].
Mechanism of action
A. calamus exerts therapeutic effects through various mechanisms, including the activation of glucokinase (GK) by certain lignans [PMID:37343685] and the modulation of neurotransmitters—increasing acetylcholinesterase, gamma-aminobutyric acid, serotonin, and dopamine while reducing glutamate [PMID:38643931].
Clinical evidence
Evidence DTraumatic Brain Injury (TBI)
In a Drosophila melanogaster model, hydroalcoholic extracts significantly reduced post-TBI mortality and improved locomotor function in a dose-dependent manner [PMID:38643931].
Evidence DDengue Virus (DENV2) Infection
Tatanan A isolated from the root inhibited dengue virus proliferation and infections in C6/36 and BHK-21 cells [PMID:29655694].
Evidence CCancer Chemoprevention
Alpha- and beta-asarone possess anti-tumor and chemo-preventive activities [PMID:31193009].
Evidence DBacterial Infection
Rhizome essential oil and beta-asarone demonstrated bactericidal activity, with Micrococcus luteus being particularly susceptible [PMID:27562598].
Safety & adverse effects
Reviews indicate the need to consider the toxicity of A. calamus and its products, particularly regarding the cardiovascular system [PMID:29273563].
Evidence summary
The evidence consists primarily of review articles (Level C) and in vitro or animal-based experimental studies (Level D). There are no human clinical trials reported in the provided abstracts.
PubMed sources
1.PMID: 29389665 (2018) — Acorus calamus: a bio-reserve of medicinal values. · Journal of basic and clinical physiology and pharmacology
2.PMID: 24824923 (2014) — Acorus calamus (The Healing Plant): a review on its medicinal potential, micropropagation and conservation. · Natural product research
3.PMID: 31193009 (2019) — Experimental evidence for use of Acorus calamus (asarone) for cancer chemoprevention. · Heliyon
4.PMID: 24200497 (2014) — An overview on traditional uses and pharmacological profile of Acorus calamus Linn. (Sweet flag) and other Acorus species. · Phytomedicine : international journal of phytotherapy and phytopharmacology
5.PMID: 29273563 (2018) — Is it safe to use Acorus calamus as a source of promising bioactive compounds in prevention and treatment of cardiovascular diseases?
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 39065505 (2024) — Kazakhstan Has an Unexpected Diversity of Medicinal Plants of the Genus Acorus (Acoraceae) and Could Be a Cradle of the Triploid Species A. calamus. · Plants (Basel, Switzerland)
7.PMID: 37343685 (2023) — Chemical constituents from Acorus calamus with potent anti-diabetic and hepatoprotective activities. · Fitoterapia
8.PMID: 27562598 (2016) — Acorus calamus Linn.: phytoconstituents and bactericidal property. · World journal of microbiology & biotechnology
9.PMID: 29655694 (2018) — Tatanan A from the Acorus calamus L. root inhibited dengue virus proliferation and infections. · Phytomedicine : international journal of phytotherapy and phytopharmacology
10.PMID: 38643931 (2024) — Acorus calamus Linn.: A novel neuroprotective approach for traumatic brain injury in Drosophila melanogaster. · Brain research
11.PMID: 28346359 (2017) — New Acorane-Type Sesquiterpene from Acorus calamus L. · Molecules (Basel, Switzerland)
12.PMID: 39683145 (2024) — Geographical Distribution Dynamics of Acorus calamus in China Under Climate Change. · Plants (Basel, Switzerland)
13.PMID: 32325895 (2020) — Role of Vacha (Acorus calamus Linn.) in Neurological and Metabolic Disorders: Evidence from Ethnopharmacology, Phytochemistry, Pharmacology and Clinical Study. · Journal of clinical medicine